Revisiting Best Practices in IV Preparation and Administration Post Shortages: Coming Out of the Storm:

Revisiting Best Practices in IV Preparation and Administration Post Shortages: Coming Out of the Storm

A Promotional Theater conducted at the 2018 ASHP Summer Meetings & Exhibition

Launch Presentation (90 minutes) Download Handout

Activity Overview

Because small volume parenterals (SVPs) are the foundation of basic intravenous (IV) compounding for hundreds of drugs that require further dilution, shortages of SVPs force health systems to make administrative and clinical decisions that facilitate management and conservation of IV products. Although necessary in the short term, many of these changes may not be ideal from a safety and clinical perspective. As the availability of products changes, it is important for health systems to reevaluate practices to ensure best practices, now and in the future.

In this activity, the faculty shares their insight into the patient safety dilemmas in IV preparation and administration related to drug shortages, as well as administrative needs in managing shortages. Lessons learned and strategies for developing key design and process changes in IV preparation and administration to ensure best practices and to prepare for future shortages will be addressed.

Agenda

Drug Shortages: An Overview
Patricia C. Kienle, B.S.Pharm., M.P.A., FASHP, Activity Chair

Patient Safety Dilemmas in IV Preparation and Administration Related to Drug Shortages
Kevin Hansen, Pharm.D,, M.S., BCPS

Administrative Challenges with IV Shortages
Richard Montgomery, B.S.Pharm., M.B.A.

Strategies for Maintaining Best Practices in the Face of Shortages: Discussion and Audience Questions
All Faculty

Learning Objectives

State the safety issues created when FDA-approved components of IV preparations are unavailable.
Describe a communication strategy to keep clinicians informed of changes in product availability and processes.
Identify design components of a centralized sterile compounding facility.
Identify key process changes to prepare for future shortages.

Like your favorites to provide us feedback!

Disclosures

In accordance with ACCME and ACPE Standards for Commercial Support, ASHP policy requires that all faculty, planners, reviewers, staff, and others in a position to control the content of this presentation disclose their financial relationships.

In this activity, only the individual below has disclosed a relevant financial relationship. No other persons associated with this presentation have disclosed any relevant financial relationships.

Patricia C. Kienle, B.S.Pharm., M.P.A., FASHP

Cardinal Health: employee
CriticalPoint, LLC: consultant

Target Audience

This activity was planned to meet the educational needs of pharmacy directors, assistant directors, supervisors, clinicians, and other pharmacist decision makers involved with the administrative and clinical aspects of IV preparation and administration.

Format

This activity features slide presentations, active learning, and questions/discussion with faculty. View the system requirements.

About Promotional Theaters

This Promotional Theater, conducted at the ASHP 2018 Summer Meetings and Exhibition, is a promotional activity provided by Baxter US Hospital Products and is not certified for continuing education credit. The content of this Promotional Theater and opinions expressed by presenters are those of the sponsor or presenters and not of the American Society of Health-System Pharmacists.

Provided by ASHP
Sponsored by Baxter US Hospital Products

“Insourcing” Sterile IV compounding services